PCYBY news

Latest 1 stories · newest Nov 13, 2026

PCYBY

PharmaCyte Biotech approves reverse stock split

The company approved a 1-for-19 reverse stock split and filed the amendment on Nov. 12, 2026. The change is a regulatory step often taken by companies to meet listing requirements.

Restructuring Nov 13, 2026 sentiment -0.50 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same PCYBY feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/PCYBY/newsSTART FREE